Mark A Wan insider trades: Concert Pharmaceuticals (CNCE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
and 2 more companies
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2014 | CNCE | ↓ Sell | 250,000 | $12.29 | $3.1M | Indirect | Nov 20, 2014 (2d) |
| Nov 18, 2014 | CNCE | ↓ Sell | 250,000 | $12.29 | $3.1M | Indirect | Nov 20, 2014 (2d) |
| Mar 10, 2014 | ACRX | ↓ Sell | 1,000,000 | $12.35 | $12.4M | Indirect | Mar 11, 2014 (1d) |
| Feb 19, 2014 | CNCE | ↑ Buy | 103,500 | $14.00 | $1.4M | Indirect | Feb 21, 2014 (2d) |
| Feb 19, 2014 | CNCE | ↑ Buy | 103,500 | $14.00 | $1.4M | Indirect | Feb 21, 2014 (2d) |
| Jan 30, 2013 | LPDX | ↑ Buy | 215,000 | $9.00 | $1.9M | By fund | Jan 31, 2013 (1d) |
| Dec 7, 2012 | ACRX | ↑ Buy | 2,416,918 | $3.31 | $8.0M | Indirect | Dec 11, 2012 (4d) |
| May 29, 2012 | ACRX | ↑ Buy | 284,698 | $3.40 | $968K | Indirect | May 31, 2012 (2d) |
| Feb 16, 2011 | ACRX | ↑ Buy | 1,289,790 | $5.00 | $6.4M | Indirect | Feb 18, 2011 (2d) |
| Feb 16, 2011 | ACRX | ↑ Buy | 1,289,789 | $5.00 | $6.4M | Indirect | Feb 18, 2011 (2d) |
| Feb 7, 2011 | EPOC | ↓ Sell | 292,116 | $16.00 | $4.7M | Indirect | Feb 7, 2011 (0d) |
| Feb 7, 2011 | EPOC | ↓ Sell | 292,116 | $16.00 | $4.7M | Indirect | Feb 7, 2011 (0d) |
| Mar 3, 2006 | THLD | ↓ Sell | 1,000,000 | $14.50 | $14.5M | Indirect | Mar 7, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark A Wan's insider trades
Mark A Wan is a 10% owner of Concert Pharmaceuticals (CNCE). Since Mar 3, 2006, Mark has reported 7 open-market purchases worth $26.7M and 6 sales worth $42.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (19 filings), conversions (10 filings), other transactions (6 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.